NR1H3 and Hepatic steatosis: The activation of Nrf2 suppresses the transcription of LXRα, SREBP-1c, and LXRα-dependent hepatic steatosis through FXR activation and FXR-mediated induction of SHP (Kay et al., 2011; Fan et al., 2021).